Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study.
Ruggieri S, Prosperini L, Al-Araji S, Annovazzi PO, Bisecco A, Ciccarelli O, De Stefano N, Filippi M, Fleischer V, Evangelou N, Enzinger C, Gallo A, Garjani A, Groppa S, Haggiag S, Khalil M, Lucchini M, Mirabella M, Montalban X, Pozzilli C, Preziosa P, Río J, Rocca MA, Rovira A, Stromillo ML, Zaffaroni M, Tortorella C, Gasperini C; MAGNIMS Study Group. Ruggieri S, et al. Among authors: haggiag s. J Neurol Neurosurg Psychiatry. 2024 Jan 11;95(2):142-150. doi: 10.1136/jnnp-2023-331920. J Neurol Neurosurg Psychiatry. 2024. PMID: 37775266
Painful and involuntary multiple sclerosis.
Bagnato F, Centonze D, Galgani S, Grasso MG, Haggiag S, Strano S. Bagnato F, et al. Among authors: haggiag s. Expert Opin Pharmacother. 2011 Apr;12(5):763-77. doi: 10.1517/14656566.2011.540239. Epub 2011 Feb 17. Expert Opin Pharmacother. 2011. PMID: 21323633 Free PMC article. Review.
Interferon-beta-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images.
Gasperini C, Pozzilli C, Bastianello S, Giugni E, Horsfield MA, Koudriavtseva T, Galgani S, Paolillo A, Haggiag S, Millefiorini E, Fieschi C. Gasperini C, et al. Among authors: haggiag s. J Neurol Neurosurg Psychiatry. 1999 Nov;67(5):579-84. doi: 10.1136/jnnp.67.5.579. J Neurol Neurosurg Psychiatry. 1999. PMID: 10519861 Free PMC article. Clinical Trial.
Clinical measures of disease activity in multiple sclerosis.
Pozzilli C, Gherardi M, Patrucco L, Cannoni S, Haggiag S, Faroni J. Pozzilli C, et al. Among authors: haggiag s. Electroencephalogr Clin Neurophysiol Suppl. 1999;50:560-4. Electroencephalogr Clin Neurophysiol Suppl. 1999. PMID: 10689509 Review. No abstract available.
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis.
Prosperini L, Saccà F, Cordioli C, Cortese A, Buttari F, Pontecorvo S, Bianco A, Ruggieri S, Haggiag S, Brescia Morra V, Capra R, Centonze D, Di Battista G, Ferraro E, Francia A, Galgani S, Gasperini C, Millefiorini E, Mirabella M, Pozzilli C. Prosperini L, et al. Among authors: haggiag s. J Neurol. 2017 Feb;264(2):284-294. doi: 10.1007/s00415-016-8343-5. Epub 2016 Nov 22. J Neurol. 2017. PMID: 27878443
65 results